Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118307032 | 11830703 | 2 | F | 2001 | 20160827 | 20151214 | 20160829 | EXP | NL-BRISTOL-MYERS SQUIBB COMPANY-10738367 | BRISTOL MYERS SQUIBB | 0.00 | YR | Y | 0.00000 | 20160829 | MD | NL | NL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118307032 | 11830703 | 1 | PS | STAVUDINE. | STAVUDINE | 1 | Transplacental | 80 MG, QD | U | 20412 | 80 | MG | QD | ||||||
| 118307032 | 11830703 | 2 | SS | DIDANOSINE. | DIDANOSINE | 1 | Transplacental | 400 MG, QD | U | 0 | 400 | MG | POWDER FOR ORAL SOLUTION | QD | |||||
| 118307032 | 11830703 | 3 | SS | NELFINAVIR | NELFINAVIR | 1 | Transplacental | 1250 MG, QD | U | 0 | 1250 | MG | QD | ||||||
| 118307032 | 11830703 | 4 | C | PAROXETINE. | PAROXETINE | 1 | Transplacental | 20 MG, QD | U | 0 | 20 | MG | QD | ||||||
| 118307032 | 11830703 | 5 | C | PAROXETINE. | PAROXETINE | 1 | Transplacental | 10 MG, QD | U | 0 | 10 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118307032 | 11830703 | 1 | Product used for unknown indication |
| 118307032 | 11830703 | 2 | Product used for unknown indication |
| 118307032 | 11830703 | 3 | Product used for unknown indication |
| 118307032 | 11830703 | 4 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118307032 | 11830703 | OT |
| 118307032 | 11830703 | DS |
| 118307032 | 11830703 | CA |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118307032 | 11830703 | Foetal exposure during pregnancy | |
| 118307032 | 11830703 | Hepatic function abnormal | |
| 118307032 | 11830703 | Hepatomegaly | |
| 118307032 | 11830703 | Hypertrophic cardiomyopathy | |
| 118307032 | 11830703 | Macrosomia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |